CA2348739C - Methods of conversion of interferon isoforms and products thereof - Google Patents

Methods of conversion of interferon isoforms and products thereof Download PDF

Info

Publication number
CA2348739C
CA2348739C CA2348739A CA2348739A CA2348739C CA 2348739 C CA2348739 C CA 2348739C CA 2348739 A CA2348739 A CA 2348739A CA 2348739 A CA2348739 A CA 2348739A CA 2348739 C CA2348739 C CA 2348739C
Authority
CA
Canada
Prior art keywords
protein
pyruvate
adjunct
isoform
conversion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2348739A
Other languages
English (en)
French (fr)
Other versions
CA2348739A1 (en
Inventor
Susan Cannon-Carlson
Andres Frei
Seoju Lee
Roland Mengisen
Marcio Voloch
David C. Wylie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CA2348739A1 publication Critical patent/CA2348739A1/en
Application granted granted Critical
Publication of CA2348739C publication Critical patent/CA2348739C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2348739A 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof Expired - Fee Related CA2348739C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19054298A 1998-11-12 1998-11-12
US09/190,542 1998-11-12
PCT/US1999/020900 WO2000029440A1 (en) 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof

Publications (2)

Publication Number Publication Date
CA2348739A1 CA2348739A1 (en) 2000-05-25
CA2348739C true CA2348739C (en) 2010-05-11

Family

ID=22701766

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2348739A Expired - Fee Related CA2348739C (en) 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof

Country Status (27)

Country Link
EP (2) EP1894944B1 (no)
JP (3) JP4468585B2 (no)
KR (1) KR100922454B1 (no)
CN (2) CN100390197C (no)
AR (1) AR023906A1 (no)
AT (2) ATE409706T1 (no)
AU (1) AU766309B2 (no)
BR (1) BR9915257A (no)
CA (1) CA2348739C (no)
CY (2) CY1110444T1 (no)
CZ (2) CZ302402B6 (no)
DE (2) DE69939657D1 (no)
DK (2) DK1894944T3 (no)
ES (2) ES2348104T3 (no)
HK (2) HK1035544A1 (no)
HU (1) HU228265B1 (no)
ID (1) ID28552A (no)
IL (2) IL142546A0 (no)
NO (2) NO329483B1 (no)
NZ (1) NZ511074A (no)
PL (2) PL200274B1 (no)
PT (2) PT1129111E (no)
SI (2) SI1129111T1 (no)
SK (2) SK287372B6 (no)
TW (1) TW577894B (no)
WO (1) WO2000029440A1 (no)
ZA (1) ZA200103010B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE409706T1 (de) * 1998-11-12 2008-10-15 Schering Corp Verfahren zur umwandlung von interferon-isoformen und daraus hergestellte produkte
EP2382237A1 (en) * 2008-12-23 2011-11-02 Schering Corporation Purification of recombinantly produced interferon
AU2021258734A1 (en) * 2020-04-20 2023-01-05 Altum Pharmaceuticals Inc. Recombinant interferon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ES8308534A1 (es) 1980-01-08 1983-09-01 Biogen Nv Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos.
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4847079A (en) 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
US4732683A (en) 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
DK0679718T3 (da) * 1994-04-09 2001-10-22 Hoffmann La Roche Fremgangsmåde til fremstilling af alfa-interferon
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
ATE409706T1 (de) * 1998-11-12 2008-10-15 Schering Corp Verfahren zur umwandlung von interferon-isoformen und daraus hergestellte produkte

Also Published As

Publication number Publication date
HU228265B1 (en) 2013-02-28
HUP0104113A3 (en) 2004-04-28
ZA200103010B (en) 2002-07-11
CZ303110B6 (cs) 2012-04-04
IL142546A (en) 2013-07-31
ES2348104T3 (es) 2010-11-30
ES2315019T3 (es) 2009-03-16
TW577894B (en) 2004-03-01
SK6172001A3 (en) 2001-10-08
PL201341B1 (pl) 2009-04-30
JP2006348056A (ja) 2006-12-28
EP1894944A1 (en) 2008-03-05
EP1129111A1 (en) 2001-09-05
JP2010209117A (ja) 2010-09-24
WO2000029440A1 (en) 2000-05-25
JP4468585B2 (ja) 2010-05-26
NO20100775L (no) 2001-05-11
NO329483B1 (no) 2010-10-25
DE69942655D1 (de) 2010-09-16
NO331699B1 (no) 2012-02-27
PL348162A1 (en) 2002-05-06
CY1110444T1 (el) 2015-04-29
SK287564B6 (sk) 2011-02-04
NO20012327L (no) 2001-05-11
DK1129111T3 (da) 2009-01-05
PT1129111E (pt) 2008-12-22
KR20010080336A (ko) 2001-08-22
CZ20011303A3 (cs) 2001-08-15
AU6387099A (en) 2000-06-05
ATE476445T1 (de) 2010-08-15
HUP0104113A2 (hu) 2002-03-28
EP1129111B1 (en) 2008-10-01
DK1894944T3 (da) 2010-10-18
SI1129111T1 (sl) 2009-06-30
PT1894944E (pt) 2010-10-28
CN101255188A (zh) 2008-09-03
CZ302402B6 (cs) 2011-05-04
NO20012327D0 (no) 2001-05-11
CN100390197C (zh) 2008-05-28
IL142546A0 (en) 2002-03-10
SK287372B6 (sk) 2010-08-09
ATE409706T1 (de) 2008-10-15
EP1894944B1 (en) 2010-08-04
SI1894944T1 (sl) 2010-11-30
BR9915257A (pt) 2001-08-07
DE69939657D1 (de) 2008-11-13
PL200274B1 (pl) 2008-12-31
JP2002530291A (ja) 2002-09-17
CY1110794T1 (el) 2015-06-10
NZ511074A (en) 2003-10-31
ID28552A (id) 2001-05-31
CN1326465A (zh) 2001-12-12
CA2348739A1 (en) 2000-05-25
KR100922454B1 (ko) 2009-10-21
HK1035544A1 (en) 2001-11-30
AU766309B2 (en) 2003-10-16
AR023906A1 (es) 2002-09-04
HK1112746A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
US6281337B1 (en) Methods for conversion of protein isoforms
AU650893B2 (en) O-glycosylated alpha-2 interferon
Pote et al. Otoconin-22, the major protein of aragonitic frog otoconia, is a homolog of phospholipase A2
DE69710747T2 (de) Assays für homocystein und homocysteindesulfurase aus protozoen trichomonas vaginalis
CA2348739C (en) Methods of conversion of interferon isoforms and products thereof
EP0804480B1 (en) Purified thrombopoietin and method of making it
JP2010500024A (ja) 強化された生物学的活性を有する組換えインターフェロン−β
DE69624930T2 (de) Modifizierte glutaminsäure decarboxylase (gad)
WO2024080569A1 (en) Pharmaceutical composition for treating, preventing or ameliorating gm1 gangliosidosis or morquio syndrome b and administration method thereof
JP3830179B2 (ja) 抗寄生虫剤
CZ20014480A3 (cs) Poraněním hlavy indukovaný cytoplasmatický protein váľící vápník
JP2002291478A (ja) 糖蛋白質の肝臓集積性を向上させる方法
WO1999062950A1 (en) A human ubiquinone oxireductase subunit ci-aggg homolog gene (cbfakd10)
WO2001046229A1 (en) Cytokine family member, mature 2-21
WO1999063065A1 (en) A human hematopoietic cell derived rna cyclase (hrdc) gene (cbuaea12)
WO1999063069A1 (en) Human mitochondrial processing protease beta subunit (mppb) homolog gene
WO1999062948A1 (en) A human ubiquinone oxireductase subunit ci-b22 homolog gene (cbnafa09)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20171005